Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer’s Disease-Like Pathology, Blood–Brain Barrier Disruption, and Synaptic Disorder

Molecular Neurobiology

Volumn 53, Issue 4, 2016, Pages 2451-2467

  Kamat, Pradip K ^a   Kyles, Philip ^a   Kalani, Anuradha ^a   Tyagi, Neetu ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Alzheimer s disease; Blood brain barrier dysfunction; Cerebrovascular pathology; Dementia; Homocysteine

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CLAUDIN 5; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; DIZOCILPINE; GELATINASE A; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; HYDROGEN SULFIDE; INTERCELLULAR ADHESION MOLECULE 1; MEMBRANE PROTEIN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPSE ASSOCIATED PROTEIN 97; SYNAPTOPHYSIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; UNCLASSIFIED DRUG; CADHERIN; DIZOCILPINE MALEATE; HOMOCYSTEINE; LEUKOCYTE ANTIGEN; MICROTUBULE ASSOCIATED PROTEIN; NERVE PROTEIN; VASCULAR ENDOTHELIAL CADHERIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN CIRCULATION; CAPILLARY DENSITY; CONTROLLED STUDY; DRUG MECHANISM; GELATINASE A GENE; GELATINASE B GENE; GENE EXPRESSION; INTERCELLULAR ADHESION MOLECULE 1 GENE; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PROTEIN EXPRESSION; ANIMAL; AVOIDANCE BEHAVIOR; C57BL MOUSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MEMORY; METABOLISM; MICROVASCULATURE; PATHOLOGY; PATHOPHYSIOLOGY; PERMEABILITY; SYNAPSE;

ALZHEIMER DISEASE; ANIMALS; ANTIGENS, CD; AVOIDANCE LEARNING; BLOOD-BRAIN BARRIER; CADHERINS; CEREBROVASCULAR CIRCULATION; CLAUDIN-5; CYSTATHIONINE BETA-SYNTHASE; DIZOCILPINE MALEATE; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HOMOCYSTEINE; HYDROGEN SULFIDE; INTERCELLULAR ADHESION MOLECULE-1; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MEMORY; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; MICROVESSELS; NERVE TISSUE PROTEINS; PERMEABILITY; RNA, MESSENGER; SYNAPSES;

EID: 84930153636     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9212-4     Document Type: Article

References (40)

1. Brustolin S, Giugliani R, Felix TM (2010) Genetics of homocysteine metabolism and associated disorders. Braz J Med Biol Res 43:1–7
2. Nilsson K, Gustafson L, Hultberg B (2010) Plasma homocysteine and cognition in elderly patients with dementia or other psychogeriatric diseases. Dement Geriatr Cogn Disord 30:198–204
3. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, Wilson PW, Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 346:476–483
4. McCaddon A, Hudson P, Davies G, Hughes A, Williams JH, Wilkinson C (2001) Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 12:309–313
5. McCaddon A, Regland B (2006) Homocysteine and cognition—no longer a hypothesis? Med Hypotheses 66:682–683
6. Luchsinger JA, Tang MX, Shea S, Miller J, Green R, Mayeux R (2004) Plasma homocysteine levels and risk of Alzheimer disease. Neurology 62:1972–1976
7. Ravaglia G, Forti P, Maioli F, Scali RC, Saccheitti L, Talerico T, Mantovani V, Bianchin M (2004) Homocysteine and cognitive performance in healthy elderly subjects. Arch Gerontol Geriatr Suppl 9:349–357
8. Zhuo JM, Wang H, Pratico D (2011) Is hyperhomocysteinemia an Alzheimer’s disease (AD) risk factor, an AD marker, or neither? Trends Pharmacol Sci 32:562–571
9. Collingridge GL, Isaac JT, Wang YT (2004) Receptor trafficking and synaptic plasticity. Nat Rev Neurosci 5:952–962
10. Perez-Otano I, Ehlers MD (2004) Learning from NMDA receptor trafficking: clues to the development and maturation of glutamatergic synapses. Neurosignals 13:175–189
11. Rai S, Kamat PK, Nath C, Shukla R (2013) A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats. J Neuroimmunol 254:1–9
12. Lee SH, Sharma M, Sudhof TC, Shen J (2014) Synaptic function of nicastrin in hippocampal neurons. Proc Natl Acad Sci U S A 111:8973–8978
13. Ethell IM, Ethell DW (2007) Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J Neurosci Res 85:2813–2823
14. Bozdagi O, Nagy V, Kwei KT, Huntley GW (2007) In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity. J Neurophysiol 98:334–344
15. Michaluk P, Mikasova L, Groc L, Frischknecht R, Choquet D, Kaczmarek L (2009) Matrix metalloproteinase-9 controls NMDA receptor surface diffusion through integrin beta1 signaling. J Neurosci 29:6007–6012
16. Kalani A, Kamat PK, Tyagi SC, Tyagi N (2013) Synergy of homocysteine, microRNA, and epigenetics: a novel therapeutic approach for stroke. Mol Neurobiol 48:157–168
17. Nagy V, Bozdagi O, Matynia A, Balcerzyk M, Okulski P, Dzwonek J, Costa RM, Silva AJ et al (2006) Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J Neurosci 26:1923–1934
18. Kamat PK, Kalani A, Givvimani S, Sathnur PB, Tyagi SC, Tyagi N (2013) Hydrogen sulfide attenuates neurodegeneration and neurovascular dysfunction induced by intracerebral-administered homocysteine in mice. Neuroscience 252:302–319
19. Kamat PK, Rai S, Swarnkar S, Shukla R, Ali S, Najmi AK, Nath C (2013) Okadaic acid-induced Tau phosphorylation in rat brain: role of NMDA receptor. Neuroscience 238:97–113
20. Lyon L, Saksida LM, Bussey TJ (2012) Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models. Psychopharmacology (Berl) 220:647–672
21. Lominadze D, Tyagi N, Sen U, Ovechkin A, Tyagi SC (2012) Homocysteine alters cerebral microvascular integrity and causes remodeling by antagonizing GABA-A receptor. Mol Cell Biochem 371:89–96
22. Glowinski J, Iversen LL (1966) Regional studies of catecholamines in the rat brain. I. The disposition of [3H] norepinephrine, [3H] dopamine and [3H] dopa in various regions of the brain. J Neurochem 13:655–669
23. Ravaglia G, Forti P, Maioli F, Zanardi V, Dalmonte E, Grossi G, Cucinotta D, Macini P et al (2000) Blood homocysteine and vitamin B levels are not associated with cognitive skills in healthy normally ageing subjects. J Nutr Health Aging 4:218–222
24. O’Brien JT, Eagger S, Syed GM, Sahakian BJ, Levy R (1992) A study of regional cerebral blood flow and cognitive performance in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 55:1182–1187
25. Prohovnik I, Mayeux R, Sackeim HA, Smith G, Stern Y, Alderson PO (1988) Cerebral perfusion as a diagnostic marker of early Alzheimer’s disease. Neurology 38:931–937
26. Nash DT, Fillit H (2006) Cardiovascular disease risk factors and cognitive impairment. Am J Cardiol 97:1262–1265
27. Tota S, Kamat PK, Awasthi H, Singh N, Raghubir R, Nath C, Hanif K (2009) Candesartan improves memory decline in mice: involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin. Behav Brain Res 199:235–240
28. Claudio L (1996) Ultrastructural features of the blood–brain barrier in biopsy tissue from Alzheimer’s disease patients. Acta Neuropathol 91:6–14
29. Kook SY, Seok Hong H, Moon M, Mook-Jung I (2013) Disruption of blood–brain barrier in Alzheimer disease pathogenesis. Tissue Barriers 1:e23993
30. Rosenberg GA (2002) Matrix metalloproteinases in neuroinflammation. Glia 39:279–291
31. Yong VW, Power C, Forsyth P, Edwards DR (2001) Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2:502–511
32. Foster CA, Mechtcheriakova D, Storch MK, Balatoni B, Howard LM, Bornancin F, Wlachos A, Sobanov J et al (2009) FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage. Brain Pathol 19:254–266
33. Frohman EM, Frohman TC, Gupta S, de Fougerolles A, van den Noort S (1991) Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer’s disease. J Neurol Sci 106:105–111
34. Wilker EH, Alexeeff SE, Poon A, Litonjua AA, Sparrow D, Vokonas PS, Mittleman MA, Schwartz J (2009) Candidate genes for respiratory disease associated with markers of inflammation and endothelial dysfunction in elderly men. Atherosclerosis 206:480–485
35. Rai S, Kamat PK, Nath C, Shukla R (2014) Glial activation and post-synaptic neurotoxicity: the key events in Streptozotocin (ICV) induced memory impairment in rats. Pharmacol Biochem Behav 117:104–117
36. Kamat PK, Rai S, Swarnkar S, Shukla R, Nath C (2014) Mechanism of synapse redox stress in Okadaic acid (ICV) induced memory impairment: role of NMDA receptor. Neurochem Int 76:32–41
37. Lee H, Lee EJ, Song YS, Kim E (2014) Long-term depression-inducing stimuli promote cleavage of the synaptic adhesion molecule NGL-3 through NMDA receptors, matrix metalloproteinases and presenilin/gamma-secretase. Philos Trans R Soc Lond B Biol Sci 369:20130158
38. Li W, Yu J, Liu Y, Huang X, Abumaria N, Zhu Y, Huang X, Xiong W et al (2014) Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer inverted question marks disease mouse model. Mol Brain 7:65
39. Spires-Jones TL, Hyman BT (2014) The intersection of amyloid beta and tau at synapses in Alzheimer’s disease. Neuron 82:756–771
40. van der Zee EA (2014) Synapses, spines and kinases in mammalian learning and memory, and the impact of aging. Neurosci Biobehav Rev 50C:77–85